WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Type 2 Diabetes
Interventions
DRUG

Colesevelam hydrochloride

Trial Locations (47)

Unknown

Birmingham

Tuscumbia

Little Rock

Searcy

Concord

Irvine

La Jolla

Los Angeles

Los Gatos

West Hills

Coral Gables

Miami

New Port Richey

Pembroke Pines

West Palm Beach

Atlanta

Chicago

Indianapolis

New Orleans

Boston

Kansas City

St Louis

Rochester

Charlotte

Hickory

Statesville

Winston-Salem

Cincinnati

Cleveland

Marion

Perrysburg

Oklahoma City

Tulsa

Portland

Beaver

Charleston

Bristol

Dallas

Houston

Midland

San Antonio

Arlington

Richmond

Lakewood

Renton

Mexico City

Lima

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY